Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7602885 | 8053117 | I | 7602885-4 | 20110603 | 20110621 | 20110630 | EXP | VISP-NO-1106S-0235 | GE HEALTHCARE | 70 | YR | F | N | 20110629 | OT | INDIA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7602885 | 1016981772 | PS | VISIPAQUE | 1 | INTRA-ARTERIAL | 200 ML, SINGLE DOSE, INTRA-ARTERIAL | D | D | 11246280 | 020351 | |
| 7602885 | 1017029316 | C | MIDAZ (MIDAZOLAM HYDROCHLORIDE) | 2 | |||||||
| 7602885 | 1017029317 | C | SUPACEF (CEFUROXIME SODIUM) | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 7602885 | 1016981772 | PRODUCT USED FOR UNKNOWN INDICATION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 7602885 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 7602885 | INFUSION RELATED REACTION |
| 7602885 | CHILLS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 7602885 | FGN |
| 7602885 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 7602885 | 1016981772 | 20110603 | 20110603 |